Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-21-020001

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 16, 2021 165.57M sh
Cash And Equivalents Q2 2021 · Jun 30, 2021 $12.66K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $742
Current Liabilities Q2 2021 · Jun 30, 2021 $3.92M
Current Liabilities Q2 2021 · Dec 31, 2020 $3.78M
Total Liabilities Q2 2021 · Jun 30, 2021 $4.6M
Total Liabilities Q2 2021 · Dec 31, 2020 $4.41M
Current Assets Q2 2021 · Jun 30, 2021 $672.38K
Current Assets Q2 2021 · Dec 31, 2020 $722.46K
Total Assets Q2 2021 · Jun 30, 2021 $4.49M
Total Assets Q2 2021 · Dec 31, 2020 $4.71M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$688.7K
Net Income Q2 2021 · Jun 30, 2020 −$317.74K
Net Income Q2 2021 · Jun 30, 2020 −$1.34M
Net Income Q2 2021 · Mar 31, 2020 −$1.02M
Operating Income Q2 2021 · Jun 30, 2020 −$164.44K
Operating Income Q2 2021 · Jun 30, 2020 −$670.79K
Gross Profit Q2 2021 · Jun 30, 2020 $445.7K
Gross Profit Q2 2021 · Jun 30, 2020 $370.28K
Revenue Q2 2021 · Jun 30, 2020 $610.54K
Revenue Q2 2021 · Jun 30, 2020 $802.58K